A guide to nanosafety testing: Considerations on cytotoxicity testing in different cell models

Christian Riebeling, Jean Pascal Piret, Bénédicte Trouiller, Inge Nelissen, Christelle Saout, Olivier Toussaint, Andrea Haase

Research output: Contribution to journalArticle

Abstract

Safety testing of nanoparticles (NPs) relies on robust, predictive, and reproducible methods. Integrated test strategies usually start with the assessment of in vitro cytotoxicity. Methods for this purpose are only partially established for NPs. The aim of this study was to evaluate three cytotoxicity assays for their applicability to NPs in several human cell models representing the most important NP target organs and to compare cell responses. The assays covered different biological principles, i.e. ATP content, redox metabolism, and membrane permeability, as well as different read-out principles, i.e. luminescence, colorimetry, and fluorescence. For all assays standard operating procedures were developed. A549 and NCI-H441 lung epithelial cells in single and in co-culture with THP-1 derived macrophages served as lung epithelial models. Normal human epidermal keratinocytes and in vitro reconstituted human epidermis were employed as skin models. Undifferentiated and differentiated Caco-2 gut epithelial cells were applied as gut epithelial models. Primary CD34-derived dendritic cells (CD34-DCs) served as an immune model. We used well-characterized model NPs, i.e. 50 nm amine-modified and 50 nm carboxyl-modified polystyrene NPs (PS-NH2 and PS-COOH, respectively). PS-COOH NPs showed no effect in any test while PS-NH2 displayed cytotoxicity in most cell models. CD34-DCs was the most sensitive cell model tested. The tetrazolium-based MTS assay was the most robust assay in our study, applicable to all cell models investigated. Therefore, this assay could become an integral part of a NP testing strategy. Other assays might be also useful, depending on the cell model or the type of investigation.

LanguageEnglish
Pages1-10
Number of pages10
JournalNanoImpact
Volume10
DOIs
Publication statusPublished - 1 Apr 2018

Fingerprint

Cytotoxicity
Nanoparticles
Assays
Testing
Dendritic Cells
Epithelial Cells
Colorimetry
Lung
Safety testing
Polystyrenes
Coculture Techniques
Luminescence
Keratinocytes
Epidermis
permeability
Macrophages
Adenosinetriphosphate
Oxidation-Reduction
Amines
Permeability

Keywords

  • Cell viability
  • Cytotoxicity
  • Nanoparticles
  • Reproducibility

Cite this

Riebeling, Christian ; Piret, Jean Pascal ; Trouiller, Bénédicte ; Nelissen, Inge ; Saout, Christelle ; Toussaint, Olivier ; Haase, Andrea. / A guide to nanosafety testing : Considerations on cytotoxicity testing in different cell models. In: NanoImpact. 2018 ; Vol. 10. pp. 1-10.
@article{46363673ed33468d9f34c2ac94e79cb9,
title = "A guide to nanosafety testing: Considerations on cytotoxicity testing in different cell models",
abstract = "Safety testing of nanoparticles (NPs) relies on robust, predictive, and reproducible methods. Integrated test strategies usually start with the assessment of in vitro cytotoxicity. Methods for this purpose are only partially established for NPs. The aim of this study was to evaluate three cytotoxicity assays for their applicability to NPs in several human cell models representing the most important NP target organs and to compare cell responses. The assays covered different biological principles, i.e. ATP content, redox metabolism, and membrane permeability, as well as different read-out principles, i.e. luminescence, colorimetry, and fluorescence. For all assays standard operating procedures were developed. A549 and NCI-H441 lung epithelial cells in single and in co-culture with THP-1 derived macrophages served as lung epithelial models. Normal human epidermal keratinocytes and in vitro reconstituted human epidermis were employed as skin models. Undifferentiated and differentiated Caco-2 gut epithelial cells were applied as gut epithelial models. Primary CD34-derived dendritic cells (CD34-DCs) served as an immune model. We used well-characterized model NPs, i.e. 50 nm amine-modified and 50 nm carboxyl-modified polystyrene NPs (PS-NH2 and PS-COOH, respectively). PS-COOH NPs showed no effect in any test while PS-NH2 displayed cytotoxicity in most cell models. CD34-DCs was the most sensitive cell model tested. The tetrazolium-based MTS assay was the most robust assay in our study, applicable to all cell models investigated. Therefore, this assay could become an integral part of a NP testing strategy. Other assays might be also useful, depending on the cell model or the type of investigation.",
keywords = "Cell viability, Cytotoxicity, Nanoparticles, Reproducibility",
author = "Christian Riebeling and Piret, {Jean Pascal} and B{\'e}n{\'e}dicte Trouiller and Inge Nelissen and Christelle Saout and Olivier Toussaint and Andrea Haase",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.impact.2017.11.004",
language = "English",
volume = "10",
pages = "1--10",
journal = "NanoImpact",
issn = "2452-0748",
publisher = "Elsevier BV",

}

A guide to nanosafety testing : Considerations on cytotoxicity testing in different cell models. / Riebeling, Christian; Piret, Jean Pascal; Trouiller, Bénédicte; Nelissen, Inge; Saout, Christelle; Toussaint, Olivier; Haase, Andrea.

In: NanoImpact, Vol. 10, 01.04.2018, p. 1-10.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A guide to nanosafety testing

T2 - NanoImpact

AU - Riebeling, Christian

AU - Piret, Jean Pascal

AU - Trouiller, Bénédicte

AU - Nelissen, Inge

AU - Saout, Christelle

AU - Toussaint, Olivier

AU - Haase, Andrea

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Safety testing of nanoparticles (NPs) relies on robust, predictive, and reproducible methods. Integrated test strategies usually start with the assessment of in vitro cytotoxicity. Methods for this purpose are only partially established for NPs. The aim of this study was to evaluate three cytotoxicity assays for their applicability to NPs in several human cell models representing the most important NP target organs and to compare cell responses. The assays covered different biological principles, i.e. ATP content, redox metabolism, and membrane permeability, as well as different read-out principles, i.e. luminescence, colorimetry, and fluorescence. For all assays standard operating procedures were developed. A549 and NCI-H441 lung epithelial cells in single and in co-culture with THP-1 derived macrophages served as lung epithelial models. Normal human epidermal keratinocytes and in vitro reconstituted human epidermis were employed as skin models. Undifferentiated and differentiated Caco-2 gut epithelial cells were applied as gut epithelial models. Primary CD34-derived dendritic cells (CD34-DCs) served as an immune model. We used well-characterized model NPs, i.e. 50 nm amine-modified and 50 nm carboxyl-modified polystyrene NPs (PS-NH2 and PS-COOH, respectively). PS-COOH NPs showed no effect in any test while PS-NH2 displayed cytotoxicity in most cell models. CD34-DCs was the most sensitive cell model tested. The tetrazolium-based MTS assay was the most robust assay in our study, applicable to all cell models investigated. Therefore, this assay could become an integral part of a NP testing strategy. Other assays might be also useful, depending on the cell model or the type of investigation.

AB - Safety testing of nanoparticles (NPs) relies on robust, predictive, and reproducible methods. Integrated test strategies usually start with the assessment of in vitro cytotoxicity. Methods for this purpose are only partially established for NPs. The aim of this study was to evaluate three cytotoxicity assays for their applicability to NPs in several human cell models representing the most important NP target organs and to compare cell responses. The assays covered different biological principles, i.e. ATP content, redox metabolism, and membrane permeability, as well as different read-out principles, i.e. luminescence, colorimetry, and fluorescence. For all assays standard operating procedures were developed. A549 and NCI-H441 lung epithelial cells in single and in co-culture with THP-1 derived macrophages served as lung epithelial models. Normal human epidermal keratinocytes and in vitro reconstituted human epidermis were employed as skin models. Undifferentiated and differentiated Caco-2 gut epithelial cells were applied as gut epithelial models. Primary CD34-derived dendritic cells (CD34-DCs) served as an immune model. We used well-characterized model NPs, i.e. 50 nm amine-modified and 50 nm carboxyl-modified polystyrene NPs (PS-NH2 and PS-COOH, respectively). PS-COOH NPs showed no effect in any test while PS-NH2 displayed cytotoxicity in most cell models. CD34-DCs was the most sensitive cell model tested. The tetrazolium-based MTS assay was the most robust assay in our study, applicable to all cell models investigated. Therefore, this assay could become an integral part of a NP testing strategy. Other assays might be also useful, depending on the cell model or the type of investigation.

KW - Cell viability

KW - Cytotoxicity

KW - Nanoparticles

KW - Reproducibility

UR - http://www.scopus.com/inward/record.url?scp=85035033240&partnerID=8YFLogxK

U2 - 10.1016/j.impact.2017.11.004

DO - 10.1016/j.impact.2017.11.004

M3 - Article

VL - 10

SP - 1

EP - 10

JO - NanoImpact

JF - NanoImpact

SN - 2452-0748

ER -